What's Happening?
The Centers for Medicare and Medicaid Services (CMS) has proposed significant changes to the 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment Systems. The proposal includes a net 2.4% rate increase
for outpatient services and ASCs, which combines a 3.2% projected hospital market basket increase with a 0.8 percentage point productivity adjustment. This would result in an overall 1.9% increase in total payments over the 2026 calendar year, amounting to $1.8 billion. However, the proposal has faced criticism from hospital industry groups due to the 'insufficient' pay increases and changes to the 340B drug discount program. The proposed changes include a cut in 340B reimbursements to 33.4% below the average sales price, offset by an 8.44% increase in non-drug service payments. CMS aims to align drug payments with acquisition costs and reduce site-of-care disparities, but hospitals argue these changes could threaten care delivery, especially for underserved communities.
Why It's Important?
The proposed changes by CMS are significant as they aim to control healthcare costs and ensure Medicare payments reflect actual service costs. However, the hospital industry is concerned that these changes could impose financial burdens on hospitals, particularly those serving underserved communities. The reduction in 340B reimbursements could impact hospitals' ability to provide affordable care, as the program is crucial for supporting hospitals that serve low-income patients. The proposal also seeks to encourage more outpatient care, which could lead to cost savings but may also challenge hospitals that rely on inpatient services. The broader impact includes potential shifts in how and where healthcare services are delivered, affecting both providers and patients.
What's Next?
CMS is currently accepting public comments on the proposed rule for 60 days, with a final decision expected in late fall. Stakeholders, including hospital associations and healthcare providers, are likely to continue lobbying against the proposed changes, particularly the 340B reimbursement cuts. The outcome of this proposal could influence future healthcare policy and payment systems, potentially leading to further reforms aimed at cost control and efficiency in healthcare delivery.
